Dr. Smith brings 30 years of clinical and translational research experience in obesity, diabetes, and metabolism with over 300 scientific publications
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
The primary objective of the study is to assess the safety and tolerability of SUVN-I6107 by monitoring adverse events (AEs), clinical laboratory, vital signs and electrocardiographs
Increases speed to market for drug developers working on nucleic acid therapeutics
Acquisition expands high-value medical platform
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
Subscribe To Our Newsletter & Stay Updated
